# Travoprost Intraocular Implant in Conjunction With Cataract Surgery

> **NCT06061718** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Glaukos Corporation** · enrollment: 60 (actual)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** iDose TR

## Key facts

- **NCT ID:** NCT06061718
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-11
- **Primary completion:** 2024-03-18
- **Final completion:** 2024-12-20
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06061718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06061718, "Travoprost Intraocular Implant in Conjunction With Cataract Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06061718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*